These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 16958826)

  • 1. A six-year evaluation of methadone prescribing practices at a substance misuse treatment centre in the UK.
    Dickinson GL; Rostami-Hodjegan A; Lagundoye O; Seivewright N; Pratt P; Lennard MS
    J Clin Pharm Ther; 2006 Oct; 31(5):477-84. PubMed ID: 16958826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A six-year evaluation of methadone prescribing practices at a substance misuse treatment centre in the UK.
    Newman RG
    J Clin Pharm Ther; 2007 Jun; 32(3):325; author reply 325-6. PubMed ID: 17489886
    [No Abstract]   [Full Text] [Related]  

  • 3. A qualitative study exploring the reason for low dosage of methadone prescribed in the MMT clinics in China.
    Lin C; Detels R
    Drug Alcohol Depend; 2011 Aug; 117(1):45-9. PubMed ID: 21310554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Injectable methadone prescribing in the United Kingdom--current practice and future policy guidelines.
    Sarfraz A; Alcorn RJ
    Subst Use Misuse; 1999 Oct; 34(12):1709-21. PubMed ID: 10499416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 15-Year survival and retention of patients in a general hospital-affiliated methadone maintenance treatment (MMT) center in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2010 Mar; 107(2-3):141-8. PubMed ID: 19914783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel.
    Peles E; Schreiber S; Adelson M
    Drug Alcohol Depend; 2006 May; 82(3):211-7. PubMed ID: 16219428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996-2006.
    Nosyk B; Marsh DC; Sun H; Schechter MT; Anis AH
    J Subst Abuse Treat; 2010 Jul; 39(1):22-31. PubMed ID: 20418051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient satisfaction with methadone maintenance treatment: the relevance of participation in treatment and social functioning.
    Trujols J; Garijo I; Siñol N; del Pozo J; Portella MJ; Pérez de los Cobos J
    Drug Alcohol Depend; 2012 Jun; 123(1-3):41-7. PubMed ID: 22071121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of time spent in treatment and dropout status on rates of convictions, cautions and imprisonment over 5 years in a primary care-led methadone maintenance service.
    Oliver P; Keen J; Rowse G; Ewins E; Griffiths L; Mathers N
    Addiction; 2010 Apr; 105(4):732-9. PubMed ID: 20403022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benzodiazepine abuse in a methadone maintenance treatment clinic in Israel: characteristics and a pharmacotherapeutic approach.
    Bleich A; Gelkopf M; Weizman T; Adelson M
    Isr J Psychiatry Relat Sci; 2002; 39(2):104-12. PubMed ID: 12227225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician peer assessments for compliance with methadone maintenance treatment guidelines.
    Strike C; Wenghofer E; Gnam W; Hillier W; Veldhuizen S; Millson M
    J Contin Educ Health Prof; 2007; 27(4):208-13. PubMed ID: 18085599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socioeconomic determinants of planned methadone treatment.
    Rivers PA; Dobalian A; Oyana TJ; Bae S
    Am J Health Behav; 2006; 30(5):451-9. PubMed ID: 16893307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patterns of abstinence or continued drug use among methadone maintenance patients and their relation to treatment retention.
    White WL; Campbell MD; Spencer RD; Hoffman HA; Crissman B; DuPont RL
    J Psychoactive Drugs; 2014; 46(2):114-22. PubMed ID: 25052787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between high methadone doses and methadone serum levels in methadone maintenance treatment (MMT) patients.
    Adelson M; Peles E; Bodner G; Kreek MJ
    J Addict Dis; 2007; 26(1):15-26. PubMed ID: 17439864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The aging methadone maintenance patient: treatment adjustment, long-term success, and quality of life.
    Rajaratnam R; Sivesind D; Todman M; Roane D; Seewald R
    J Opioid Manag; 2009; 5(1):27-37. PubMed ID: 19344046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retention in methadone maintenance treatment in mainland China, 2004-2012: a literature review.
    Zhou K; Zhuang G
    Addict Behav; 2014 Jan; 39(1):22-9. PubMed ID: 24090627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug misuse.
    Ashworth AJ; Kidd BA
    Br J Gen Pract; 1998 Jul; 48(432):1435-6. PubMed ID: 9800413
    [No Abstract]   [Full Text] [Related]  

  • 18. Does methadone maintenance treatment based on the new national guidelines work in a primary care setting?
    Keen J; Oliver P; Rowse G; Mathers N
    Br J Gen Pract; 2003 Jun; 53(491):461-7. PubMed ID: 12939891
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methadone maintenance treatment in the Swiss Canton of Vaud: demographic and clinical data on 1,782 ambulatory patients.
    Pelet A; Doll S; Huissoud T; Resplendino J; Besson J; Favrat B
    Eur Addict Res; 2005; 11(2):99-106. PubMed ID: 15785071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.